<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Etiology of hemoptysis in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Etiology of hemoptysis in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Etiology of hemoptysis in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David H Ingbar, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Steven E Weinberger, MD, MACP, FRCP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David J Feller-Kopman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H11003158">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term hemoptysis refers to expectoration of blood originating from the lower respiratory tract (ie, from below the vocal cords). Pseudohemoptysis, expectoration of blood that comes from the upper respiratory tract and/or the upper gastrointestinal tract, can mimic hemoptysis.
        </p>
        <p>
         There are several sources of bleeding within the lung and endobronchial tree that can be responsible for hemoptysis. Causes of life-threatening and non-life-threatening hemoptysis are described here. The diagnostic evaluation and management of hemoptysis are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4394.html" rel="external">
          "Evaluation and management of life-threatening hemoptysis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4333.html" rel="external">
          "Evaluation of nonlife-threatening hemoptysis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1847984969">
         <span class="h1">
          BRONCHIAL VERSUS PULMONARY ARTERIAL ORIGINS OF HEMOPTYSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blood supply to the lungs is derived from the pulmonary arteries or the bronchial arteries. Supply from the non-bronchial systemic circulation (eg, aorta, intercostal, coronary, thoracic, axillary, subclavian, and upper and lower inferior phrenic arteries) is an anatomical variant in a small percentage of patients (&lt;5 percent). The pulmonary artery circulation supply is a low-pressure system mostly supplying the lung parenchyma; most episodes of hemoptysis are non-life-threatening and originate from the pulmonary artery circulation. In contrast, the bronchial artery circulation is relatively high-pressure from the systemic circulation mostly supplying the endobronchial tree. Although the bronchial artery circulation is responsible for only 2 percent of the total vascular supply to the lung, bleeding from a bronchial artery is the cause of life-threatening hemoptysis in 90 percent of cases. For this reason, patients with non-resolving life-threatening hemoptysis undergo arterial embolization primarily in the bronchial circulation, and less often in the pulmonary circulation. (See
         <a class="medical medical_review" href="/z/d/html/4394.html" rel="external">
          "Evaluation and management of life-threatening hemoptysis", section on 'Arteriography'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3672963296">
         <span class="h1">
          CAUSES OF NON-LIFE-THREATENING HEMOPTYSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most episodes of hemoptysis are non-life-threatening. There are numerous causes of non-life-threatening bleeding from the lower respiratory tract, which are listed in the table  (
         <a class="graphic graphic_table graphicRef96527" href="/z/d/graphic/96527.html" rel="external">
          table 1
         </a>
         ). The most common causes of non-life-threatening hemoptysis in developed countries are acute bronchitis, bronchiectasis, and bronchial neoplasms (primary or secondary) [
         <a href="#rid1">
          1-6
         </a>
         ]. In a brief report of 606 hemoptysis patients from five Italian hospitals, malignancy (19 percent), pneumonia/lung abscess (19 percent), and bronchiectasis (15 percent) were the most common causes [
         <a href="#rid5">
          5
         </a>
         ]. In contrast, in developing countries, infections due to
         <em>
          Mycobacterium tuberculosis
         </em>
         and
         <em>
          Paragonimus westermani
         </em>
         and non-cystic fibrosis (CF)-related bronchiectasis are more common causes [
         <a href="#rid1">
          1,7-9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3723001692">
         <span class="h2">
          Airways diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hemoptysis is not an uncommon symptom of pathologic airway processes due to the proximal location of bronchi and their bronchial arterial supply.
        </p>
        <p class="headingAnchor" id="H2059210850">
         <span class="h3">
          Bronchitis and bronchiectasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Inflammatory diseases, such as bronchitis and bronchiectasis (eg, due to cystic fibrosis, immunodeficiency, and prior pneumonia) are common causes of hemoptysis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In bronchitis, minor amounts of hemoptysis may be seen during an acute flare but hemoptysis is unusual during the chronic phase. Life-threatening hemoptysis from acute bronchitis is very unusual without additional contributing factors (such as anticoagulation). (See
         <a class="medical medical_review" href="/z/d/html/6870.html" rel="external">
          "Acute bronchitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1455.html" rel="external">
          "Chronic obstructive pulmonary disease: Diagnosis and staging"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In bronchiectasis, minor amounts of blood that are mixed with expectorated phlegm (“streaky” in appearance) are commonplace during the chronic phase. Less commonly, larger amounts that appear as bright red blood and clots may occur during an acute flare. In contrast to acute bronchitis, bronchiectasis is a common cause of life-threatening hemoptysis. Non-life-threatening hemoptysis is likely due to the chronic airway inflammation that is characteristic of bronchiectasis, while life-threatening hemoptysis is likely due to rapid bleeding from a ruptured tortuous bronchial artery or from hypertrophied submucosal and peribronchial blood vessels. Because more patients with CF now survive into adulthood, recurrent hemoptysis in CF patients with bronchiectasis is occurring more frequently. (See
         <a class="medical medical_review" href="/z/d/html/1444.html" rel="external">
          "Clinical manifestations and diagnosis of bronchiectasis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H870498850">
         <span class="h3">
          Bronchial neoplasm
         </span>
         <span class="headingEndMark">
          —
         </span>
         Malignant neoplasms such as primary bronchogenic carcinoma, endobronchial metastatic carcinoma (most commonly from melanoma or from breast, colon, or renal cell carcinoma), and bronchial carcinoid can all cause hemoptysis. Non-life-threatening hemoptysis occurs in 7 to 10 percent of patients with lung cancer at the time of presentation and in approximately 20 percent of patients at some time during the course of their illness [
         <a href="#rid10">
          10
         </a>
         ]. The most common clinical pattern of hemoptysis due to lung cancer is intermittent small amounts of hemoptysis lasting more than two weeks. Less commonly, bronchogenic carcinoma causes life-threatening hemoptysis. (See
         <a class="local">
          'Bronchogenic carcinoma'
         </a>
         below.)
        </p>
        <p>
         Bronchial carcinoid, a highly vascular tumor that is unrelated to smoking, should be considered in a young or middle-aged nonsmoker with recurrent hemoptysis. The amount of bleeding is variable. Their highly vascular nature raises concern regarding bleeding with biopsy such that some experts defer to surgical excision rather than bronchoscopic biopsy; however the risk of bleeding may be overestimated [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4883.html" rel="external">
          "Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging"
         </a>
         .)
        </p>
        <p>
         In patients with acquired immunodeficiency syndrome (AIDS), Kaposi sarcoma involving the airways (and/or the pulmonary parenchyma) is also a potential cause of hemoptysis. (See
         <a class="medical medical_review" href="/z/d/html/4883.html" rel="external">
          "Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4326.html" rel="external">
          "Pulmonary involvement in AIDS-related Kaposi sarcoma"
         </a>
         and
         <a class="local">
          'Bronchogenic carcinoma'
         </a>
         below.)
        </p>
        <p>
         Benign neoplasms such as hemangiomas and adenomas are rare causes of hemoptysis; when hemangioma is suspected, it should not be biopsied since bleeding may be life-threatening. The rare vascular endothelial malignancy, angiosarcoma, can cause diffuse alveolar hemorrhage [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="local">
          'Uncommon etiologies'
         </a>
         below and
         <a class="local">
          'Bronchogenic carcinoma'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1624110753">
         <span class="h3">
          Other airway diseases
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Foreign bodies
         </strong>
         – Hemoptysis can be caused by direct trauma or local inflammation from an inhaled foreign body (FB). Less commonly hemoptysis can be due to FB-related obstruction that results in a necrotizing pneumonia or focal bronchiectasis. (See
         <a class="medical medical_review" href="/z/d/html/4387.html" rel="external">
          "Airway foreign bodies in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Broncholiths
         </strong>
         – Erosion of a calcified lymph node into the airway can cause hemoptysis [
         <a href="#rid13">
          13
         </a>
         ]. With the decline in prevalence of tuberculosis this is less common, but in the United States it most commonly occurs due to old histoplasma infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Airway infections
         </strong>
         – Airway mucosal infection with herpes virus [
         <a href="#rid14">
          14-16
         </a>
         ] or fungal species [
         <a href="#rid17">
          17-19
         </a>
         ] can cause hemoptysis, particularly in immunocompromised patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fistulas
         </strong>
         – Fistula formation between a blood vessel and the tracheobronchial tree can occur when there is chronic vascular inflammation (eg, aortic aneurysm, aortic surgery such as stent placement, aortic infection, or an indwelling vascular device) or airway inflammation (eg, tracheobronchial medical device such as an airway stent). Vascular fistulas are at high risk of causing life-threatening hemoptysis, which is often heralded by smaller non-life threatening episodes of bleeding.(See
         <a class="local">
          'Uncommon etiologies'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dieulafoy lesion
         </strong>
         – A Dieulafoy lesion is a dilated aberrant submucosal vessel (superficial, subepithelial bronchial artery lesions contiguous with the bronchial mucosa). Bleeding is more likely to result from such lesions in the gastrointestinal tract, but several case reports describe hemoptysis from airway lesions [
         <a href="#rid20">
          20-25
         </a>
         ]. Bronchoscopically, the lesions appear nodular and are red in color; however, some are subtle but can be seen as abnormal vascular lesions on endobronchial ultrasound or bronchial angiography [
         <a href="#rid25">
          25
         </a>
         ]. Endobronchial biopsy should be avoided due to the risk of causing massive hemoptysis [
         <a href="#rid25">
          25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2644.html" rel="external">
          "Causes of upper gastrointestinal bleeding in adults", section on 'Dieulafoy's lesion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H508962063">
         <span class="h2">
          Pulmonary parenchymal diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Causes of bleeding originating from the pulmonary parenchyma fall into several major categories listed below.
        </p>
        <p class="headingAnchor" id="H1414507093">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of lung parenchymal infections, especially tuberculosis, mycetoma, lung abscess, and necrotizing pneumonia can cause hemoptysis, most often due to erosion into blood vessels. Hemoptysis from infection can be life-threatening, particularly among patients with an aspergilloma and tuberculosis [
         <a href="#rid26">
          26,27
         </a>
         ]. Among those with aspergilloma, hemoptysis is relatively common, occurring in up to 40 percent of patients in some series. In the developing world,
         <em>
          P. westermani
         </em>
         is a common cause of hemoptysis, and hemorrhagic dengue fever is associated with hemoptysis in about one-fourth of patients [
         <a href="#rid28">
          28
         </a>
         ]. Hemoptysis is a late manifestation of Ebola virus. It may also occur in some patients with Coronavirus disease-2019 (COVID-19) respiratory infections [
         <a href="#rid29">
          29,30
         </a>
         ]. Other infections are listed in the table  (
         <a class="graphic graphic_table graphicRef96527" href="/z/d/graphic/96527.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications", section on 'Hemoptysis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2441.html" rel="external">
          "Chronic pulmonary aspergillosis: Epidemiology, clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7030.html" rel="external">
          "Lung abscess in adults"
         </a>
         and
         <a class="local">
          'Fungal infections'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3888279073">
         <span class="h3">
          Other parenchymal diseases
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rheumatic and immune disorders
         </strong>
         – Rheumatic and immune disorders can all cause non-life-threatening as well as life-threatening hemoptysis. Disorders include anti-glomerular basement membrane (ie, Goodpasture) syndrome, lupus pneumonitis/vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, primary antiphospholipid antibody syndrome, Behçet syndrome, pulmonary capillaritis, and idiopathic pulmonary hemosiderosis. Many of these conditions cause diffuse alveolar hemorrhage, rather than focal bleeding. The degree of alveolar bleeding may not be reflected in the volume of expectorated blood since less coughing may occur. (See
         <a class="medical medical_review" href="/z/d/html/4681.html" rel="external">
          "Pulmonary manifestations of systemic lupus erythematosus in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">
          "Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4318.html" rel="external">
          "Idiopathic pulmonary hemosiderosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">
          "Clinical manifestations and diagnosis of Behçet syndrome", section on 'Pulmonary disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3041.html" rel="external">
          "Glomerular disease: Evaluation and differential diagnosis in adults"
         </a>
         and
         <a class="local">
          'Uncommon etiologies'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic disorders of connective tissue
         </strong>
         – Hemoptysis has been reported as a complication of the vascular type of Ehlers-Danlos syndrome, associated with genetic variants of the collagen type III gene (OMIM 25940258) [
         <a href="#rid31">
          31,32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14920.html" rel="external">
          "Clinical manifestations and diagnosis of Ehlers-Danlos syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Catamenial hemoptysis
         </strong>
         – Catamenial hemoptysis is characterized by recurrent hemoptysis that is coincident with menses. The cause is intrathoracic endometriosis, usually involving the pulmonary parenchyma but occasionally affecting the airways [
         <a href="#rid33">
          33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6687.html" rel="external">
          "Clinical features, diagnostic approach, and treatment of adults with thoracic endometriosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H930095811">
         <span class="h2">
          Pulmonary vascular disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although this category overlaps with pulmonary parenchymal disease, the disorders mentioned below are those in which the primary pathology is intrinsic to the pulmonary vasculature or affects the pressure within these vessels. In many cases hemoptysis can be life-threatening. (See
         <a class="local">
          'Common etiologies'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Elevated pulmonary capillary pressure
         </strong>
         – Elevated pulmonary
         <strong>
          venous
         </strong>
         pressure, as seen with mitral stenosis, congenital heart disease, significant left ventricular failure, pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis, and fibrosing mediastinitis can be associated with hemoptysis. Pulmonary
         <strong>
          arterial
         </strong>
         hypertension is a rare cause of hemoptysis. (See
         <a class="medical medical_review" href="/z/d/html/112486.html" rel="external">
          "Pulmonary hypertension due to left heart disease (group 2 pulmonary hypertension) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8173.html" rel="external">
          "Rheumatic mitral stenosis: Clinical manifestations and diagnosis", section on 'Hemoptysis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8269.html" rel="external">
          "Epidemiology, pathogenesis, clinical evaluation, and diagnosis of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4397.html" rel="external">
          "Mediastinal granuloma and fibrosing mediastinitis", section on 'Clinical presentation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8249.html" rel="external">
          "Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults", section on 'Symptoms'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary arteriovenous malformation (PAVM)
         </strong>
         – Hemoptysis may occur with PAVM (idiopathic or heritable hemorrhagic telangiectasia) and may be life-threatening (eg, during pregnancy). (See
         <a class="medical medical_review" href="/z/d/html/8267.html" rel="external">
          "Pulmonary arteriovenous malformations: Epidemiology, etiology, and pathology in adults"
         </a>
         and
         <a class="local">
          'Uncommon etiologies'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary or bronchial artery aneurysms
         </strong>
         – Hughes-Stovin syndrome, which may be a variant of Behçet syndrome, is characterized by the presence of multiple pulmonary and/or bronchial aneurysms that can cause life-threatening hemoptysis [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">
          "Clinical manifestations and diagnosis of Behçet syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary artery pseudoaneurysms
         </strong>
         – Pulmonary artery pseudoaneurysms (Rasmussen aneurysm), which are usually caused by infection, neoplasms, or trauma, have a predilection for peripheral pulmonary arteries and may be single or multiple [
         <a href="#rid35">
          35
         </a>
         ]. Active tuberculosis and paragonimiasis may cause sudden rupture of a Rasmussen aneurysm [
         <a href="#rid36">
          36,37
         </a>
         ]. Bleeding is more likely to be life-threatening.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary embolism (thrombotic, fat, septic)
         </strong>
         – Hemoptysis is a rare presenting manifestation of pulmonary embolism and is usually non-life-threatening unless the patient is receiving anticoagulant therapy. The presumed mechanism is pulmonary infarction, which usually occurs with smaller, more distal thromboembolism. (See
         <a class="medical medical_review" href="/z/d/html/8253.html" rel="external">
          "Epidemiology and pathogenesis of acute pulmonary embolism in adults", section on 'Clinical presentation, evaluation, and diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8261.html" rel="external">
          "Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary capillaritis
         </strong>
         – Pulmonary capillaritis due to collagen vascular diseases, for example, may present with hemoptysis due to vessel inflammation. (See
         <a class="medical medical_review" href="/z/d/html/4380.html" rel="external">
          "Overview of pleuropulmonary diseases associated with rheumatoid arthritis", section on 'Vasculitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes", section on 'Pulmonary capillaritis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1096759310">
         <span class="h2">
          Trauma and bleeding disorders
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bleeding disorders
         </strong>
         – Bleeding disorders (eg, thrombocytopenia, disseminated intravascular coagulation, platelet dysfunction syndromes, von Willebrand disease) and use of anticoagulant or antiplatelet medications may cause episodes of non-life-threatening or life-threatening hemoptysis [
         <a href="#rid38">
          38-40
         </a>
         ]. Therapeutic anticoagulation is not usually sufficient as a sole explanation for hemoptysis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Airway or parenchymal trauma
         </strong>
         – Both penetrating and blunt chest trauma can cause hemoptysis. (See
         <a class="medical medical_review" href="/z/d/html/353.html" rel="external">
          "Initial evaluation and management of blunt thoracic trauma in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13861.html" rel="external">
          "Initial evaluation and management of chest wall trauma in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Iatrogenic injury
         </strong>
         – Hemoptysis can result from a variety of medical interventions, especially percutaneous or transbronchial lung biopsy and ablative procedures involving the airway as well as stent placement and balloon dilation procedures. Most cases are non-life-threatening. However, hemoptysis may be life-threatening when patients have a bleeding diathesis. (See
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Bleeding'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4407.html" rel="external">
          "Bronchoscopic cryotechniques in adults", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4408.html" rel="external">
          "Endobronchial brachytherapy", section on 'Early'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4382.html" rel="external">
          "Endobronchial photodynamic therapy in the management of airway disease in adults", section on 'Photodynamic therapy specific'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Pulmonary artery perforation is a rare complication of pulmonary artery catheter placement, which can be associated with life-threatening bleeding and death. Localized pulmonary infarction with hemoptysis can also occur when a catheter is left in too distal a location or when a balloon is inflated for a prolonged period. (See
         <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">
          "Pulmonary artery catheterization: Indications, contraindications, and complications in adults", section on 'Use and maintenance'
         </a>
         and
         <a class="local">
          'Uncommon etiologies'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hemoptysis has been reported to occur after pulmonary vein isolation using cryoballoon ablation for atrial fibrillation [
         <a href="#rid41">
          41-44
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">
          "Pulmonary artery catheterization: Indications, contraindications, and complications in adults", section on 'Use and maintenance'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1007.html" rel="external">
          "Overview of catheter ablation of cardiac arrhythmias", section on 'Cryothermal energy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/95704.html" rel="external">
          "Catheter ablation for the treatment of atrial fibrillation: Technical considerations for non-electrophysiologists", section on 'Pulmonary vein isolation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1349062859">
         <span class="h2">
          Miscellaneous
         </span>
         <span class="headingEndMark">
          —
         </span>
         Miscellaneous causes of pulmonary hemorrhage that should be considered in the appropriate clinical setting include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Drugs and toxins:
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cocaine-induced pulmonary hemorrhage
         </strong>
         – Hemoptysis has been described in 6 percent of habitual smokers of free-base cocaine ("crack") and has also been associated with diffuse alveolar hemorrhage. Levamisole-contaminated cocaine has been associated with pulmonary hemorrhage in several case reports. (See
         <a class="medical medical_review" href="/z/d/html/4343.html" rel="external">
          "Pulmonary complications of cocaine use", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="8683" href="/z/d/drug information/8683.html" rel="external">
          Bevacizumab
         </a>
         <strong>
          treatment
         </strong>
         – Hemoptysis, ranging from minor to life-threatening, has been reported with the use of the vascular endothelial growth factor (VEGF) inhibitor, bevacizumab [
         <a href="#rid45">
          45,46
         </a>
         ]. Although the mechanism is uncertain, it may be related to destruction of tissue as a result of VEGF inhibition, particularly in the setting of a cavitating lung cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nitrogen dioxide exposure in indoor ice arenas
         </strong>
         – Hemoptysis has been reported in ice hockey players exposed to high levels of nitrogen dioxide created by malfunctioning propane-powered ice surfacing equipment and inadequate ventilation [
         <a href="#rid47">
          47-49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          E-cigarette or vaping product use associated lung injury (EVALI)
         </strong>
         – In a case series of 53 patients with vaping-associated lung injury, hemoptysis was reported in six patients (11 percent) at the time of presentation [
         <a href="#rid50">
          50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/122671.html" rel="external">
          "E-cigarette or vaping product use-associated lung injury (EVALI)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other drugs
         </strong>
         – Other drugs associated with non-life-threatening hemoptysis include
         <a class="drug drug_general" data-topicid="91067" href="/z/d/drug information/91067.html" rel="external">
          riociguat
         </a>
         [
         <a href="#rid51">
          51
         </a>
         ],
         <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">
          hydralazine
         </a>
         (ie, hydralazine-induced vasculitis [
         <a href="#rid52">
          52
         </a>
         ]), and argemone alkaloid-contaminated cooking oil [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Miscellaneous and idiopathic
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Idiopathic pulmonary hemosiderosis (see
         <a class="medical medical_review" href="/z/d/html/4318.html" rel="external">
          "Idiopathic pulmonary hemosiderosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fibrosing mediastinitis (see
         <a class="medical medical_review" href="/z/d/html/4397.html" rel="external">
          "Mediastinal granuloma and fibrosing mediastinitis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulmonary amyloid (see
         <a class="medical medical_review" href="/z/d/html/5589.html" rel="external">
          "Overview of amyloidosis", section on 'Pulmonary disease'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11003737">
         <span class="h1">
          CAUSES OF LIFE-THREATENING HEMOPTYSIS
         </span>
        </p>
        <p class="headingAnchor" id="H1154877620">
         <span class="h2">
          Definition
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term life-threatening hemoptysis (formerly massive hemoptysis) is generally used to describe the expectoration of a large amount of blood and/or a rapid rate of bleeding [
         <a href="#rid8">
          8,54-57
         </a>
         ]; however, the precise thresholds that constitute life-threatening hemoptysis are controversial. We generally prefer to use the term “life-threatening hemoptysis” when hemoptysis results in a life-threatening event, including significant airway obstruction, significant gas exchange alterations, or hemodynamic instability [
         <a href="#rid54">
          54
         </a>
         ]. Criteria based solely on the volume of blood cannot be used precisely since quantifying the amount of blood that a patient has expectorated is challenging. Nonetheless, in our clinical practice, we also consider hemoptysis to be life-threatening when there has been approximately 150 mL of blood expectorated in a 24-hour period or bleeding at a rate ≥100 mL/hour [
         <a href="#rid54">
          54
         </a>
         ]. For practical purposes, more than 150 mL is easily quantifiable by patients as roughly a half cup of blood in 24 hours.
        </p>
        <p class="headingAnchor" id="H1426080690">
         <span class="h2">
          Common etiologies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Any etiology associated with non-life-threatening hemoptysis  (
         <a class="graphic graphic_table graphicRef96527" href="/z/d/graphic/96527.html" rel="external">
          table 1
         </a>
         ) can also cause life-threatening hemoptysis, but a few etiologies account for most episodes of the latter.
        </p>
        <p>
         While comprehensive epidemiologic data are lacking, common causes of life-threatening hemoptysis in developed countries include bronchiectasis (most often cystic fibrosis [CF]-related), tuberculosis (TB), airway neoplasms (primary and metastatic), and fungal infections (particularly aspergilloma) [
         <a href="#rid58">
          58-60
         </a>
         ]. In a series of 58 patients undergoing arterial embolization for hemoptysis, underlying causes included CF-related bronchiectasis (40 percent), lung metastasis (14 percent), lung cancer (12 percent), and fungal infection (7 percent) [
         <a href="#rid58">
          58
         </a>
         ]. In developing countries, TB remains the predominant cause [
         <a href="#rid7">
          7,8,55,61-63
         </a>
         ]. However, there is significant geographic variation in the etiologic frequencies of life-threatening hemoptysis as shown in the table  (
         <a class="graphic graphic_table graphicRef66122" href="/z/d/graphic/66122.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4654462">
         <span class="h3">
          Bronchiectasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In bronchiectasis, rapid bleeding and life-threatening hemoptysis can occur due to rupture of tortuous bronchial arteries or the submucosal capillary plexus, both of which are subjected to high pressure from the systemic circulation. The improved survival of patients with CF into adulthood has made CF-associated bronchiectasis an increasingly common cause of life-threatening hemoptysis in developed countries [
         <a href="#rid64">
          64
         </a>
         ], although bronchiectasis from any cause may be associated with significant hemoptysis. (See
         <a class="medical medical_review" href="/z/d/html/1444.html" rel="external">
          "Clinical manifestations and diagnosis of bronchiectasis in adults", section on 'Etiologies'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11003744">
         <span class="h3">
          Tuberculosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Life-threatening hemoptysis can be due to either active or prior TB [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Active TB – Life-threatening hemoptysis due to active TB can occur in the setting of cavitary or noncavitary disease. The cause of the bleeding is usually due to bronchial arterial vessel ulceration [
         <a href="#rid10">
          10
         </a>
         ]. Less often, active TB may cause sudden rupture of a Rasmussen aneurysm (ie, pseudoaneurysm) of the pulmonary artery [
         <a href="#rid36">
          36
         </a>
         ]. There is some uncertainty about whether similar pseudoaneurysms can also arise from TB-infected bronchial arteries. (See
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications", section on 'Hemoptysis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prior TB – There are multiple causes of hemoptysis due to inactive prior TB. These include the erosion of a healed calcified lymph node (ie, broncholith) through a bronchial artery and into an airway, bronchiectasis due to structural lung damage from prior TB, a mycetoma in an old TB lung cavity, and scar carcinoma in areas of healed TB. Late rupture of a Rasmussen aneurysm also may occur in patients with prior TB [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11003758">
         <span class="h3">
          Fungal infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fungal infections in the lung have increased in frequency, especially among patients with pre-existing cavitary disease and in immunocompromised patients (eg, hematopoietic cell transplantation).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aspergilloma – Aspergilloma is a common cause of life-threatening hemoptysis. An aspergilloma is a fungus ball, also known as a mycetoma, composed of
         <em>
          Aspergillus
         </em>
         hyphae, fibrin, mucus, and cellular debris that is found within a pre-existing pulmonary cavity. The cavity may derive from various causes, such as chronic pulmonary sarcoidosis, emphysematous bullae, septic emboli, or hydatid cyst [
         <a href="#rid26">
          26,66,67
         </a>
         ]. A mycetoma, can also be due to other fungal species. In many patients, aspergillomas (and mycetomas) are asymptomatic and non-progressive for prolonged periods of time. However, hemoptysis occurs in 50 to 90 percent of patients, at some point in their life [
         <a href="#rid10">
          10,26,27
         </a>
         ]. Hemoptysis is generally non-life-threatening but in rare cases, can be life-threatening. The exact cause of bleeding due to an aspergilloma is uncertain. (See
         <a class="medical medical_review" href="/z/d/html/2441.html" rel="external">
          "Chronic pulmonary aspergillosis: Epidemiology, clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Invasive parenchymal fungal infections – Invasive parenchymal fungal infections may also cause hemoptysis, particularly infections caused by the angioinvasive fungi including
         <em>
          Aspergillus
         </em>
         (acute or chronic necrotizing aspergillosis) and
         <em>
          Mucor
         </em>
         [
         <a href="#rid10">
          10,68
         </a>
         ]. The fungi destroy parenchymal and vascular structures, thereby inducing hemorrhage. There is increasing recognition of subacute progressive aspergillus infection in patients with chronic underlying lung disease, including severe chronic obstructive pulmonary disease (COPD). When invasive parenchymal fungal infection occurs after hematopoietic stem cell transplantation, bleeding may be more likely when bone marrow production of neutrophils returns (about day 100), since local inflammation may increase [
         <a href="#rid69">
          69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2441.html" rel="external">
          "Chronic pulmonary aspergillosis: Epidemiology, clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2454.html" rel="external">
          "Epidemiology and clinical manifestations of invasive aspergillosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2465.html" rel="external">
          "Mucormycosis (zygomycosis)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Acute dimorphic fungal infections (eg, histoplasmosis, blastomycosis) rarely cause hemoptysis and, when they do, it is likely a consequence of mucosal erosion. Prior histoplasmosis has been reported as a potential cause of hemoptysis, either due to the erosion of a calcified lymph node through an airway and vessel, or the effects of fibrosing mediastinitis. (See
         <a class="medical medical_review" href="/z/d/html/2450.html" rel="external">
          "Pathogenesis and clinical features of pulmonary histoplasmosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2437.html" rel="external">
          "Clinical manifestations and diagnosis of blastomycosis", section on 'Pulmonary involvement'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4654544">
         <span class="h3">
          Bronchogenic carcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchogenic cancer accounts for approximately 5 to 30 percent of cases of life-threatening hemoptysis, depending on the report [
         <a href="#rid70">
          70-72
         </a>
         ]. In many cases, life-threatening bleeding may be heralded by smaller, sentinel bleeding events during the prior weeks [
         <a href="#rid73">
          73
         </a>
         ]. Patients typically have large, centrally located tumors, especially squamous cell carcinoma. In a case series of 125 patients with life-threatening hemoptysis related to non-small cell lung cancer, bleeding was due to bronchial artery involvement in 82 percent, while bleeding due to involvement of the main pulmonary artery was rare (6 percent) [
         <a href="#rid74">
          74
         </a>
         ]. Approximately half of these patients had squamous cell carcinoma.
        </p>
        <p>
         Carcinoid tumors and endobronchial hemangiomas are highly vascular and are rare causes of life-threatening hemoptysis. (See
         <a class="medical medical_review" href="/z/d/html/4883.html" rel="external">
          "Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging"
         </a>
         and
         <a class="local">
          'Bronchial neoplasm'
         </a>
         above.)
        </p>
        <p>
         Rare cancers such as papillary thyroid carcinoma causing tracheal invasion, malignant triton tumor (an aggressive peripheral nerve sheath tumor), and giant hamartoma have been reported to cause life-threatening hemoptysis [
         <a href="#rid75">
          75-77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3346192383">
         <span class="h2">
          Uncommon etiologies
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are several other causes of life-threatening hemoptysis that should be kept in mind in the absence of the more common causes listed above. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other lung infections
         </strong>
         – Other lung infections (particularly bacterial lung abscess and/or necrotizing pneumonia) can also cause life-threatening hemoptysis. Regardless of the type of lung infection, bleeding may occur acutely from necrosis of lung tissue or rupture of hypertrophied bronchial arteries due to inflammation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Bacterial pneumonia (without necrosis) occasionally causes life-threatening hemoptysis, especially in individuals with a bleeding diathesis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In developing countries, parasitic infections are common causes of life-threatening hemoptysis, particularly paragonimiasis in Southeast Asia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Case reports of life-threatening hemoptysis have been described in patients with leptospirosis [
         <a href="#rid78">
          78
         </a>
         ] and septic pulmonary emboli from right-sided infective endocarditis. (See
         <a class="medical medical_review" href="/z/d/html/4337.html" rel="external">
          "Overview of pulmonary disease in people who inject drugs", section on 'Septic emboli'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunologic lung diseases
         </strong>
         – Diffuse parenchymal lung diseases with an immunologic basis can cause life-threatening hemoptysis, probably due to pulmonary capillaritis. Examples include anti-glomerular basement membrane (anti-GBM; Goodpasture) disease, granulomatosis with polyangiitis, systemic lupus erythematosus (SLE), idiopathic pulmonary hemosiderosis, primary antiphospholipid antibody syndrome, Behçet syndrome, and microscopic polyangiitis [
         <a href="#rid79">
          79
         </a>
         ]. Patients with these diseases may also present with diffuse alveolar hemorrhage (DAH)  (
         <a class="graphic graphic_table graphicRef72772 graphicRef51544" href="/z/d/graphic/72772.html" rel="external">
          table 3A-B
         </a>
         ). However, in DAH, the expectorated volume of hemoptysis may be relatively small compared with the amount of parenchymal bleeding. The reason for this observation is that the alveolar location of the bleeding may not stimulate the cough reflex to the same extent as bleeding in the airway. (See
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chemotherapy and bone marrow transplantation
         </strong>
         – Patients who are undergoing chemotherapy for leukemia or who have received a hematopoietic stem cell transplant (HSCT) rarely may have sudden, life-threatening pulmonary hemorrhage that is frequently fatal. In some cases this is due to DAH, an early complication of HSCT while in others, it is due to idiopathic pneumonia syndrome (IPS), which is a late complication of HSCT. Postmortem pathology suggests IPS is due to diffuse lung injury, presumably from a combination of drugs, radiation, and/or thrombocytopenia [
         <a href="#rid80">
          80
         </a>
         ]. In cases of DAH or IPS, there may also be contributions from underlying fungal or viral infection. Idiopathic pneumonia syndrome is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4342.html" rel="external">
          "Pulmonary complications after autologous hematopoietic cell transplantation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4339.html" rel="external">
          "Pulmonary complications after allogeneic hematopoietic cell transplantation: Causes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary vascular diseases
         </strong>
         – Cardiac and vascular etiologies are potential, albeit infrequent, causes of life-threatening hemoptysis in adults.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulmonary arteriovenous malformations (PAVMs) can bleed regardless of whether or not they are due to hereditary hemorrhagic telangiectasia (HHT; also called Osler-Weber-Rendu syndrome) or idiopathic [
         <a href="#rid81">
          81,82
         </a>
         ]. In one series, more than 8 percent of patients with HHT-PAVMs had an episode of life-threatening hemoptysis [
         <a href="#rid81">
          81
         </a>
         ]. An increased risk of life-threatening hemoptysis has been reported during pregnancy in patients with PAVMs. (See
         <a class="medical medical_review" href="/z/d/html/8268.html" rel="external">
          "Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1345.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)", section on 'Pulmonary AVMs'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16891.html" rel="external">
          "Therapeutic approach to adult patients with pulmonary arteriovenous malformations", section on 'Pregnancy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mitral stenosis increases resistance in the pulmonary veins, accompanied by reversal of blood flow from the pulmonary capillaries into the bronchial veins. While hemoptysis is often minor, bronchial varix rupture may result in sudden, life-threatening bleeding ("pulmonary apoplexy"). This is prone to manifest at times of either increased pulmonary blood flow (exercise, pregnancy) or increased blood volume (pregnancy, hypervolemia). (See
         <a class="medical medical_review" href="/z/d/html/8173.html" rel="external">
          "Rheumatic mitral stenosis: Clinical manifestations and diagnosis", section on 'Hemoptysis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulmonary embolism usually causes scant hemoptysis in association with peripheral pulmonary infarction. However, the hemoptysis may become life-threatening after the initiation of anticoagulant therapy or the use of a thrombolytic agent. (See
         <a class="medical medical_review" href="/z/d/html/8253.html" rel="external">
          "Epidemiology and pathogenesis of acute pulmonary embolism in adults", section on 'Clinical presentation, evaluation, and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Congenital heart disease or severe pulmonary hypertension can cause significant hemoptysis, especially in patients who undergo lung biopsy. (See
         <a class="medical medical_review" href="/z/d/html/6370.html" rel="external">
          "Hemoptysis in children", section on 'Pulmonary vascular disorders'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acquired and iatrogenic trauma
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Penetrating, rather than blunt, trauma may result in life-threatening hemoptysis (eg, gunshot wound). (See
         <a class="medical medical_review" href="/z/d/html/13862.html" rel="external">
          "Initial evaluation and management of penetrating thoracic trauma in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Right heart catheterization (ie, pulmonary artery catheterization) can result in pulmonary artery perforation and the sudden onset of life-threatening hemoptysis. Predispositions include pulmonary hypertension and having the catheter tip too distal in the pulmonary circulation, particularly for relatively long periods of time. The latter can also induce hemoptysis due to pulmonary infarction. (See
         <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">
          "Pulmonary artery catheterization: Indications, contraindications, and complications in adults", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Life-threatening hemoptysis may result from a variety of medical interventions, including percutaneous or transbronchial lung biopsy (&lt;2 percent), cryobiopsy (&lt;20 percent) [
         <a href="#rid83">
          83,84
         </a>
         ], central vein venipuncture during pacemaker insertion [
         <a href="#rid85">
          85
         </a>
         ], and ablative procedures for endobronchial masses. (See
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Bleeding'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4407.html" rel="external">
          "Bronchoscopic cryotechniques in adults", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4408.html" rel="external">
          "Endobronchial brachytherapy", section on 'Early'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4382.html" rel="external">
          "Endobronchial photodynamic therapy in the management of airway disease in adults", section on 'Photodynamic therapy specific'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fistulas
         </strong>
         – Although an uncommon cause of hemoptysis, fistulas between the aorta and the airway (especially the left bronchopulmonary tree) are frequently associated with aneurysms of the thoracic aorta and are fatal if not diagnosed and surgically treated [
         <a href="#rid86">
          86
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8192.html" rel="external">
          "Clinical manifestations and diagnosis of thoracic aortic aneurysm", section on 'Clinical presentations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Tracheo-innominate fistulas are a rare but potentially life-threatening complication of tracheostomy, occurring most often if the tracheostomy tube is placed too low [
         <a href="#rid87">
          87,88
         </a>
         ]. The tube can erode directly into the innominate artery, which crosses the anterolateral surface of the trachea at the level of the upper sternum. Bronchial stents are another source of fistula formation [
         <a href="#rid89">
          89
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/131521.html" rel="external">
          "Tracheostomy: Postoperative care, maintenance, and complications in adults", section on 'Late (≥7 to 10 days)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute bronchitis
         </strong>
         – It is controversial whether acute bronchitis alone is sufficient to cause life-threatening hemoptysis and in our experience it is rare. Many clinicians believe that coagulopathy or other contributing factors must be present for life-threatening hemoptysis to occur in the setting of acute bronchitis alone. Older case series reported bronchitis as the cause of life-threatening hemoptysis in 5 to 37 percent of cases [
         <a href="#rid1">
          1,7,8,90
         </a>
         ]. However, since computed tomography of the chest was rarely performed in these older series, it is possible that many of the patients actually had underlying bronchiectasis. In addition, many of the reported cases did not have follow-up, so it is unclear if other underlying causes remained undiagnosed. Life-threatening hemoptysis should be attributed to bronchitis only presumptively after careful and complete workup.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2643376935">
         <span class="h1">
          CRYPTOGENIC HEMOPTYSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depending upon the study, up to 30 percent of patients with hemoptysis have no cause identified even after careful evaluation, including bronchoscopy and chest computed tomography. These patients are classified as having either cryptogenic or idiopathic hemoptysis [
         <a href="#rid20">
          20,91,92
         </a>
         ].
        </p>
        <p>
         Repeat investigation with recurrent events may eventually identify a cause. In a series that included 409 patients with cryptogenic hemoptysis, lung cancer developed in less than 2 percent over the ensuing five years [
         <a href="#rid93">
          93
         </a>
         ]. A separate retrospective series stressed the finding of a superficial bronchial artery beneath the bronchial epithelium (Dieulafoy disease) in a subset of patients with cryptogenic hemoptysis who required surgery for massive hemoptysis [
         <a href="#rid20">
          20
         </a>
         ]. In a series of 35 patients with cryptogenic hemoptysis, bronchial arteriography identified areas of hypervascularization or aneurysm in over 80 percent [
         <a href="#rid94">
          94
         </a>
         ]. Similar findings were reported in a separate series of 22 patients [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2827613138">
         <span class="h1">
          PSEUDOHEMOPTYSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blood from the upper respiratory tract and the upper gastrointestinal (GI) tract can be expectorated and, thus, mimic blood coming from the lower respiratory tract, a situation called pseudohemoptysis. In some occasions, upper airway and GI bleeding need to be simultaneously investigated with lower respiratory tract investigations before the true source can be confirmed. (See
         <a class="medical medical_review" href="/z/d/html/4333.html" rel="external">
          "Evaluation of nonlife-threatening hemoptysis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4394.html" rel="external">
          "Evaluation and management of life-threatening hemoptysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1371112766">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118986.html" rel="external">
          "Society guideline links: Hemoptysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11004209">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         -The term hemoptysis refers to expectoration of blood originating from the lower respiratory tract (ie, from below the vocal cords). There are several sources of bleeding within the lung and endobronchial tree that can be responsible for hemoptysis  (
         <a class="graphic graphic_table graphicRef96527" href="/z/d/graphic/96527.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Circulation source
         </strong>
         - Most episodes of hemoptysis are non-life-threatening and originate from the pulmonary artery circulation. Although the bronchial artery circulation is responsible for only 2 percent of the total vascular supply to the lung, bleeding from a bronchial artery is the cause of life-threatening hemoptysis in 90 percent of cases. (See
         <a class="local">
          'Bronchial versus pulmonary arterial origins of hemoptysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes non-life-threatening
         </strong>
         - The most common causes of non-life-threatening hemoptysis in developed countries are acute bronchitis, bronchial neoplasms, and bronchiectasis, while infections due to
         <em>
          Mycobacterium tuberculosis
         </em>
         (TB) and
         <em>
          Paragonimus westermani
         </em>
         are more common causes in developing countries  (
         <a class="graphic graphic_table graphicRef96527" href="/z/d/graphic/96527.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Causes of non-life-threatening hemoptysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Less common causes of non-life-threatening hemoptysis include other airway diseases (inhaled foreign body, vascular-airway fistulas, Dieulafoy lesions), parenchymal infections (eg, lung abscess, and aspergilloma), and immune disorders (eg, Goodpasture syndrome, systemic lupus erythematosus, granulomatosis with polyangiitis). (See
         <a class="local">
          'Common etiologies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rare etiologies include genetic disorders (eg, Ehlers-Danlos syndrome), endometriosis, pulmonary vascular disorders (eg, conditions that result in pulmonary venous and pulmonary arterial hypertension, pulmonary arterial venous malformations, aneurysms, embolism), trauma (including iatrogenic), bleeding disorders (eg, thrombocytopenia, coagulopathy), and several drugs or toxins (eg, cocaine, e-cigarette or vaping use). (See
         <a class="local">
          'Miscellaneous'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes life-threatening
         </strong>
         - We use the term “life-threatening hemoptysis” when hemoptysis results in life-threatening events, including significant airway obstruction, abnormal gas exchange, or hemodynamic instability. Hemoptysis is also considered life-threatening when there has been approximately 150 mL of blood expectorated in a 24-hour period or bleeding occurs at a rate ≥100 mL/hour. (See
         <a class="local">
          'Definition'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         While any etiology associated with non-life-threatening hemoptysis can also be life-threatening, common causes of life-threatening hemoptysis include bronchiectasis,
         <em>
         </em>
         TB, bronchogenic carcinoma, and fungal infections (particularly aspergilloma)  (
         <a class="graphic graphic_table graphicRef96527" href="/z/d/graphic/96527.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Causes of life-threatening hemoptysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cryptogenic and pseudohemoptysis
         </strong>
         - Cryptogenic (or idiopathic) hemoptysis is a term given to cases where a cause of hemoptysis is not apparent after investigation, although evaluation during repeat episodes may reveal previously unidentified lesions (eg, Dieulafoy lesion, early carcinoma, arterial lesions). Pseudohemoptysis refers to expectorated blood that arises from the upper respiratory or upper gastrointestinal tract. (See
         <a class="local">
          'Cryptogenic hemoptysis'
         </a>
         above and
         <a class="local">
          'Pseudohemoptysis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Johnston H, Reisz G. Changing spectrum of hemoptysis. Underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy. Arch Intern Med 1989; 149:1666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haro Estarriol M, Vizcaya Sánchez M, Jiménez López J, Tornero Molina A. [Etiology of hemoptysis: Prospective analysis of 752 cases]. Rev Clin Esp 2001; 201:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsoumakidou M, Chrysofakis G, Tsiligianni I, et al. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration 2006; 73:808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee BR, Yu JY, Ban HJ, et al. Analysis of patients with hemoptysis in a tertiary referral hospital. Tuberc Respir Dis (Seoul) 2012; 73:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mondoni M, Carlucci P, Job S, et al. Observational, multicentre study on the epidemiology of haemoptysis. Eur Respir J 2018; 51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Unsal E, Köksal D, Cimen F, et al. Analysis of patients with hemoptysis in a reference hospital for chest diseases. Tuberk Toraks 2006; 54:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santiago S, Tobias J, Williams AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med 1991; 151:2449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997; 112:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prasad R, Garg R, Singhal S, Srivastava P. Lessons from patients with hemoptysis attending a chest clinic in India. Ann Thorac Med 2009; 4:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cahill BC, Ingbar DH. Massive hemoptysis. Assessment and management. Clin Chest Med 1994; 15:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon RK, Britt EJ, Netzer GA, et al. Ten-year Single Center Experience of Pulmonary Carcinoid Tumors and Diagnostic Yield of Bronchoscopic Biopsy. Lung 2016; 194:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu M, Huang W, Wang Y, et al. Pulmonary angiosarcoma presenting with diffuse alveolar hemorrhage: a case report. Ann Transl Med 2021; 9:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alshabani K, Ghosh S, Arrossi AV, Mehta AC. Broncholithiasis: A Review. Chest 2019; 156:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boland AC, Iveson EH, Elliott MW. An unusual exacerbation of chronic obstructive pulmonary disease (COPD) with herpes simplex tracheitis: case report. J Med Case Rep 2007; 1:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thong L, Plant BJ, McCarthy J, Murphy DM. Herpetic tracheitis in association with rituximab therapy. Respirol Case Rep 2016; 4:e00158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sporinova B, McRae SA, Muruve DA, et al. A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis. BMC Nephrol 2019; 20:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koroscil MT, Skabelund A. Chronic Pulmonary Blastomycosis Mimicking Pulmonary Tuberculosis. Mil Med 2018; 183:e332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shuai SY, Xiong L, He XL, et al. A unique case report of endobronchial cryptococcosis and review of the literature. Respir Med Case Rep 2018; 25:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang D, Li B, Chu H, et al. Endobronchial aspergilloma: A case report and literature review. Exp Ther Med 2017; 14:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savale L, Parrot A, Khalil A, et al. Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med 2007; 175:1181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuzucu A, Gürses I, Soysal O, et al. Dieulafoy's disease: a cause of massive hemoptysis that is probably underdiagnosed. Ann Thorac Surg 2005; 80:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kolb T, Gilbert C, Fishman EK, et al. Dieulafoy's disease of the bronchus. Am J Respir Crit Care Med 2012; 186:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheth HS, Maldonado F, Lentz RJ. Two cases of Dieulafoy lesions of the bronchus with novel comorbid associations and endobronchial ablative management. Medicine (Baltimore) 2018; 97:e9754.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang RH, Li JF, Liu J, et al. [Dieulafoy disease of the bronchus: 3 cases report with literature review]. Zhonghua Jie He He Hu Xi Za Zhi 2013; 36:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qian X, Du Q, Wei N, et al. Bronchial Dieulafoy's disease: a retrospective analysis of 73 cases. BMC Pulm Med 2019; 19:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muniappan A, Tapias LF, Butala P, et al. Surgical therapy of pulmonary aspergillomas: a 30-year North American experience. Ann Thorac Surg 2014; 97:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farid S, Mohamed S, Devbhandari M, et al. Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience. J Cardiothorac Surg 2013; 8:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmed S, Mohammad WW, Hamid F, et al. The 2011 dengue haemorrhagic fever outbreak in Lahore - an account of clinical parameters and pattern of haemorrhagic complications. J Coll Physicians Surg Pak 2013; 23:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Löffler C, Mahrhold J, Fogarassy P, et al. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. Chest 2020; 158:e215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med 2020; 38:1544.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sareli AE, Janssen WJ, Sterman D, et al. Clinical problem-solving. What's the connection? - A 26-year-old white man presented to our referral hospital with a 1-month history of persistent cough productive of white sputum, which was occasionally tinged with blood. N Engl J Med 2008; 358:626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abrahamsen BJ, Kulseth MA, Paus B. A 19-year-old man with relapsing bilateral pneumothorax, hemoptysis, and intrapulmonary cavitary lesions diagnosed with vascular Ehlers-Danlos syndrome and a novel missense mutation in COL3A1. Chest 2015; 147:e166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augoulea A, Lambrinoudaki I, Christodoulakos G. Thoracic endometriosis syndrome. Respiration 2008; 75:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khalid U, Saleem T. Hughes-Stovin syndrome. Orphanet J Rare Dis 2011; 6:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen Y, Gilman MD, Humphrey KL, et al. Pulmonary Artery Pseudoaneurysms: Clinical Features and CT Findings. AJR Am J Roentgenol 2017; 208:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen, V. On haemoptysis, especially when fatal, in its anatomical and clinical aspects. Edinburgh Med J 1968; 14:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gener Idor, Charisma Idor, Serra CA. Rasmussen Aneurysm and Paragonimiasis Presented as Massive Hemoptysis. Chest 2014; 146:S112A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drent M, Wessels S, Jacobs JA, Thijssen H. Association of diffuse alveolar haemorrhage with acquired vitamin K deficiency. Respiration 2000; 67:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ikeda M, Tanaka H, Sadamatsu K. Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome. Cardiovasc Revasc Med 2011; 12:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen BC, Sheth NR, Dadzie KA, et al. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Am J Kidney Dis 2013; 62:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martí-Almor J, Jauregui-Abularach ME, Benito B, et al. Pulmonary hemorrhage after cryoballoon ablation for pulmonary vein isolation in the treatment of atrial fibrillation. Chest 2014; 145:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Opstal JM, Timmermans C, Blaauw Y, Pison L. Bronchial erosion and hemoptysis after pulmonary vein isolation by cryoballoon ablation. Heart Rhythm 2011; 8:1459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conte G, Chierchia GB, Casado-Arroyo R, et al. Pulmonary vein intramural hematoma as a complication of cryoballoon ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2013; 24:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vogler J, Fink T, Sohns C, et al. Acute Hemoptysis Following Cryoballoon Pulmonary Vein Isolation: A Multicenter Study. JACC Clin Electrophysiol 2020; 6:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006; 355:2542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho YJ, Murgu SD, Colt HG. Bronchoscopy for bevacizumab-related hemoptysis. Lung Cancer 2007; 56:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karlson-Stiber C, Höjer J, Sjöholm A, et al. Nitrogen dioxide pneumonitis in ice hockey players. J Intern Med 1996; 239:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Exposure to nitrogen dioxide in an indoor ice arena - New Hampshire, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahan ES, Martin UJ, Spungen S, et al. Chronic cough and dyspnea in ice hockey players after an acute exposure to combustion products of a faulty ice resurfacer. Lung 2007; 185:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med 2020; 382:903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghofrani HA, Galiè N, Grimminger F, et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 2013; 369:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai-Nguyen G, Modrykamien AM, Bredeweg A. Hereditary afibrinogenemia and pulmonary-renal hydralazine-induced vasculitis. Proc (Bayl Univ Med Cent) 2019; 32:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alebachew A, Aseffa A, TekleMariam S, et al. Outbreak investigation of epidemic dropsy in Addis Ababa, Ethiopia:. Ethiop Med J 2013; Suppl 2:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J 2008; 32:1131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knott-Craig CJ, Oostuizen JG, Rossouw G, et al. Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J Thorac Cardiovasc Surg 1993; 105:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amirana M, Frater R, Tirschwell P, et al. An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis. Am Rev Respir Dis 1968; 97:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinson GM, Noone PG, Mauro MA, et al. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med 1998; 157:1951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dave BR, Sharma A, Kalva SP, Wicky S. Nine-year single-center experience with transcatheter arterial embolization for hemoptysis: medium-term outcomes. Vasc Endovascular Surg 2011; 45:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khalil A, Fedida B, Parrot A, et al. Severe hemoptysis: From diagnosis to embolization. Diagn Interv Imaging 2015; 96:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xi Y, Liu D, Yang C, et al. [Cause of massive hemoptysis in critical patients and the effect of bronchial artery embolization]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2018; 30:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mal H, Rullon I, Mellot F, et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 1999; 115:996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhalla A, Pannu AK, Suri V. Etiology and outcome of moderate-to-massive hemoptysis: Experience from a tertiary care center of North India. Int J Mycobacteriol 2017; 6:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uzun O, Atasoy Y, Findik S, et al. A prospective evaluation of hemoptysis cases in a tertiary referral hospital. Clin Respir J 2010; 4:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter DK, Van Every MJ, Anthracite RF, Mack JW Jr. Massive hemoptysis in cystic fibrosis. Arch Intern Med 1983; 143:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sapra R, Sharma G, Minz AK. Rasmussen's aneurysm: A rare and forgotten cause of hemoptysis. Indian Heart J 2015; 67 Suppl 3:S53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aliyali M, Badali H, Shokohi T, et al. Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review. Mycopathologia 2016; 181:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moodley L, Pillay J, Dheda K. Aspergilloma and the surgeon. J Thorac Dis 2014; 6:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Souza LVS, Souza AS, Marchiori E. Mucormycotic Pulmonary Pseudoaneurysm Causing Fatal Hemoptysis. Arch Bronconeumol (Engl Ed) 2019; 55:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albelda SM, Talbot GH, Gerson SL, et al. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis 1985; 131:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kucukay F, Topcuoglu OM, Alpar A, et al. Bronchial Artery Embolization with Large Sized (700-900 µm) Tris-acryl Microspheres (Embosphere) for Massive Hemoptysis: Long-Term Results (Clinical Research). Cardiovasc Intervent Radiol 2018; 41:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tom LM, Palevsky HI, Holsclaw DS, et al. Recurrent Bleeding, Survival, and Longitudinal Pulmonary Function following Bronchial Artery Embolization for Hemoptysis in a U.S. Adult Population. J Vasc Interv Radiol 2015; 26:1806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shigemura N, Wan IY, Yu SC, et al. Multidisciplinary management of life-threatening massive hemoptysis: a 10-year experience. Ann Thorac Surg 2009; 87:849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller RR, McGregor DH. Hemorrhage from carcinoma of the lung. Cancer 1980; 46:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razazi K, Parrot A, Khalil A, et al. Severe haemoptysis in patients with nonsmall cell lung carcinoma. Eur Respir J 2015; 45:756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aslam W, Shakespeare A, Jones S, Ghamande S. Massive hemoptysis: an unusual presentation of papillary thyroid carcinoma due to tracheal invasion. BMJ Case Rep 2019; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scanagatta P, Furia S, Pardolesi A, et al. Worsening Hemoptysis in a Rare Intrapulmonary Triton Tumor Mimicking Lung Cancer. Ann Thorac Surg 2020; 109:e199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geramizadeh B, Mottavvas M, Zeyaian B, Amirian A. Giant hamartoma of lung presented with massive hemoptysis: A rare case report and review of the literature. Rare Tumors 2019; 11:2036361318823926.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pea L, Roda L, Boussaud V, Lonjon B. Desmopressin therapy for massive hemoptysis associated with severe leptospirosis. Am J Respir Crit Care Med 2003; 167:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scapa JV, Fishbein GA, Wallace WD, Fishbein MC. Diffuse Alveolar Hemorrhage and Pulmonary Vasculitides: Histopathologic Findings. Semin Respir Crit Care Med 2018; 39:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panoskaltsis-Mortari A, Griese M, Madtes DK, et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 2011; 183:1262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ference BA, Shannon TM, White RI Jr, et al. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994; 106:1387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158:643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Du Rand IA, Blaikley J, Booton R, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax 2013; 68 Suppl 1:i1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hetzel J, Maldonado F, Ravaglia C, et al. Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration 2018; 95:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yelgec NS, Osken A, Turkkan C, Alper AT. Subclavian vein puncture-induced massive pulmonary hemorrhage and hemoptysis during pacemaker implantation. North Clin Istanb 2018; 5:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixit MD, Gan M, Narendra NG, et al. Aortopulmonary fistula: a rare complication of an aortic aneurysm. Tex Heart Inst J 2009; 36:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hung JJ, Hsu HS, Huang CS, Yang KY. Tracheoesophageal fistula and tracheo-subclavian artery fistula after tracheostomy. Eur J Cardiothorac Surg 2007; 32:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Komatsu T, Sowa T, Fujinaga T, et al. Tracheo-innominate artery fistula: two case reports and a clinical review. Ann Thorac Cardiovasc Surg 2013; 19:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choudhary C, Bandyopadhyay D, Salman R, et al. Broncho-vascular fistulas from self-expanding metallic stents: A retrospective case review. Ann Thorac Med 2013; 8:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGuinness G, Beacher JR, Harkin TJ, et al. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:1155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest 2001; 120:1592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delage A, Tillie-Leblond I, Cavestri B, et al. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration 2010; 80:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petersen CL, Weinreich UM. Five-year follow-up of hemoptysis with no malignancy suspected on chest computed tomography: recurrence, lung cancer and mortality. Eur Clin Respir J 2019; 6:1616519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ando T, Kawashima M, Masuda K, et al. Clinical and Angiographic Characteristics of 35 Patients With Cryptogenic Hemoptysis. Chest 2017; 152:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee H, Yoon CJ, Seong NJ, et al. Cryptogenic Hemoptysis: Effectiveness of Bronchial Artery Embolization Using N-Butyl Cyanoacrylate. J Vasc Interv Radiol 2017; 28:1161.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15663 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2742442" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Changing spectrum of hemoptysis. Underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11835879" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : [Etiology of hemoptysis: Prospective analysis of 752 cases].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16446530" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23166543" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Analysis of patients with hemoptysis in a tertiary referral hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29301924" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Observational, multicentre study on the epidemiology of haemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16615016" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Analysis of patients with hemoptysis in a reference hospital for chest diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1747002" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : A reappraisal of the causes of hemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9266882" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19561915" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Lessons from patients with hemoptysis attending a chest clinic in India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8200191" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Massive hemoptysis. Assessment and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27544227" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ten-year Single Center Experience of Pulmonary Carcinoid Tumors and Diagnostic Yield of Bronchoscopic Biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33553367" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Pulmonary angiosarcoma presenting with diffuse alveolar hemorrhage: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31173766" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Broncholithiasis: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17880676" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : An unusual exacerbation of chronic obstructive pulmonary disease (COPD) with herpes simplex tracheitis: case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27512561" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Herpetic tracheitis in association with rituximab therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30704432" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29547956" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Chronic Pulmonary Blastomycosis Mimicking Pulmonary Tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30302308" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A unique case report of endobronchial cryptococcosis and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28672965" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Endobronchial aspergilloma: A case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17332480" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16122511" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Dieulafoy's disease: a cause of massive hemoptysis that is probably underdiagnosed.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23204378" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Dieulafoy's disease of the bronchus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29465555" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Two cases of Dieulafoy lesions of the bronchus with novel comorbid associations and endobronchial ablative management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24252733" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : [Dieulafoy disease of the bronchus: 3 cases report with literature review].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31170962" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Bronchial Dieulafoy's disease: a retrospective analysis of 73 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24365218" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Surgical therapy of pulmonary aspergillomas: a 30-year North American experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23915502" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23823947" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The 2011 dengue haemorrhagic fever outbreak in Lahore - an account of clinical parameters and pattern of haemorrhagic complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32622819" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32312574" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18256398" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical problem-solving. What's the connection? - A 26-year-old white man presented to our referral hospital with a 1-month history of persistent cough productive of white sputum, which was occasionally tinged with blood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25940258" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A 19-year-old man with relapsing bilateral pneumothorax, hemoptysis, and intrapulmonary cavitary lesions diagnosed with vascular Ehlers-Danlos syndrome and a novel missense mutation in COL3A1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17622704" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Thoracic endometriosis syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21489283" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Hughes-Stovin syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27656954" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Pulmonary Artery Pseudoaneurysms: Clinical Features and CT Findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : On haemoptysis, especially when fatal, in its anatomical and clinical aspects
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Rasmussen Aneurysm and Paragonimiasis Presented as Massive Hemoptysis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11124658" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Association of diffuse alveolar haemorrhage with acquired vitamin K deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21514251" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23597859" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24394827" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Pulmonary hemorrhage after cryoballoon ablation for pulmonary vein isolation in the treatment of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20601153" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Bronchial erosion and hemoptysis after pulmonary vein isolation by cryoballoon ablation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23387834" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Pulmonary vein intramural hematoma as a complication of cryoballoon ablation of paroxysmal atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32703558" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Acute Hemoptysis Following Cryoballoon Pulmonary Vein Isolation: A Multicenter Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17167137" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17368626" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Bronchoscopy for bevacizumab-related hemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8642238" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Nitrogen dioxide pneumonitis in ice hockey players.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22377844" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Exposure to nitrogen dioxide in an indoor ice arena - New Hampshire, 2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17294334" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Chronic cough and dyspnea in ice hockey players after an acute exposure to combustion products of a faulty ice resurfacer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31491072" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23883378" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Riociguat for the treatment of pulmonary arterial hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31384199" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Hereditary afibrinogenemia and pulmonary-renal hydralazine-induced vasculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24654505" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Outbreak investigation of epidemic dropsy in Addis Ababa, Ethiopia:.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18827169" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Massive haemoptysis: the definition should be revised.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8445918" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Management and prognosis of massive hemoptysis. Recent experience with 120 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5637935" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9620932" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21444351" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Nine-year single-center experience with transcatheter arterial embolization for hemoptysis: medium-term outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26141487" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Severe hemoptysis: From diagnosis to embolization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30045796" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : [Cause of massive hemoptysis in critical patients and the effect of bronchial artery embolization].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10208199" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28776532" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Etiology and outcome of moderate-to-massive hemoptysis: Experience from a tertiary care center of North India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20565491" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A prospective evaluation of hemoptysis cases in a tertiary referral hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6824394" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Massive hemoptysis in cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26995433" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Rasmussen's aneurysm: A rare and forgotten cause of hemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26666549" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24624284" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Aspergilloma and the surgeon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31113670" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Mucormycotic Pulmonary Pseudoaneurysm Causing Fatal Hemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3966697" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29067512" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Bronchial Artery Embolization with Large Sized (700-900 µm) Tris-acryl Microspheres (Embosphere) for Massive Hemoptysis: Long-Term Results (Clinical Research).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26481824" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Recurrent Bleeding, Survival, and Longitudinal Pulmonary Function following Bronchial Artery Embolization for Hemoptysis in a U.S. Adult Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19231404" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Multidisciplinary management of life-threatening massive hemoptysis: a 10-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6248189" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Hemorrhage from carcinoma of the lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25359349" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Severe haemoptysis in patients with nonsmall cell lung carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31439567" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Massive hemoptysis: an unusual presentation of papillary thyroid carcinoma due to tracheal invasion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31400331" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Worsening Hemoptysis in a Rare Intrapulmonary Triton Tumor Mimicking Lung Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30719262" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Giant hamartoma of lung presented with massive hemoptysis: A rare case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12598216" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Desmopressin therapy for massive hemoptysis associated with severe leptospirosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30404110" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Diffuse Alveolar Hemorrhage and Pulmonary Vasculitides: Histopathologic Findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21531955" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7956388" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9700146" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pulmonary arteriovenous malformations. A state of the art review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23860341" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29316560" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30688923" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Subclavian vein puncture-induced massive pulmonary hemorrhage and hemoptysis during pacemaker implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19876436" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Aortopulmonary fistula: a rare complication of an aortic aneurysm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17689090" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Tracheoesophageal fistula and tracheo-subclavian artery fistula after tracheostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22785449" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Tracheo-innominate artery fistula: two case reports and a clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23741275" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Broncho-vascular fistulas from self-expanding metallic stents: A retrospective case review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8162743" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Hemoptysis: prospective high-resolution CT/bronchoscopic correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11713139" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19996573" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31164971" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Five-year follow-up of hemoptysis with no malignancy suspected on chest computed tomography: recurrence, lung cancer and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28526654" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Clinical and Angiographic Characteristics of 35 Patients With Cryptogenic Hemoptysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28462783" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Cryptogenic Hemoptysis: Effectiveness of Bronchial Artery Embolization Using N-Butyl Cyanoacrylate.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
